ABC Heart Fail Cardiomyop 2022; 2(2): 237-238
Intermittent Inotrope Infusion Associated with Peritoneal Dialysis for Management of Advanced Heart Failure Secondary to Cardiac Amyloidosis
Ana Paula Otaviano, Breno Tadao de Paiva Eto, Pedro Vellosa Schwartzmann
Introduction
Advanced heart failure (HF) represents a therapeutic challenge, characterized by quality of life deterioration and multiple hospitalizations. When HF is secondary to cardiac amyloidosis, the recommended treatment for HF may have an unfavorable clinical course. In advanced HF cases, the clinical scenario is even more challenging.
[…]
Intermittent Inotrope Infusion Associated with Peritoneal Dialysis for Management of Advanced Heart Failure Secondary to Cardiac Amyloidosis
Keywords: Amyloidosis; Cardiotonic Agents; Heart Failure
606
